Valuation: ARPIDA

Market Cap 1.75Cr 2.19Cr 1.87Cr 1.6Cr 3.01Cr 209.19Cr 3.05Cr 21Cr 8.07Cr 105.09Cr 8.21Cr 8.03Cr 347.59Cr P/E 2024
6.22x
P/E 2025 -8.95x
Enterprise Value 1.16Cr 1.45Cr 1.24Cr 1.06Cr 2Cr 138.7Cr 2.02Cr 14Cr 5.35Cr 70Cr 5.44Cr 5.32Cr 230.45Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
58.74%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Investor Relations Contact 59 -
Director TitleAgeSince
Director/Board Member - 27/03/2025
Chairman - 27/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+5.26%+4.44%+26.03% 5.12TCr
-1.07%+2.82%+474.18%+601.24% 4.54TCr
+1.47%+9.79%+40.15%+21.21% 4.21TCr
+1.44%+7.77%+19.27%+90.94% 4.2TCr
-0.93%-4.33%+17.87%+51.96% 3.19TCr
+1.32%+7.30%+36.93%+152.36% 1.71TCr
-0.60%+1.93% - - 1.67TCr
+0.03%+3.41%+7.12%+35.49% 1.48TCr
+1.28%+5.41%+91.01%+46.93% 1.39TCr
Average +0.45%+3.68%+86.37%+128.27% 3.06TCr
Weighted average by Cap. +0.48%+3.55%+103.78%+150.02%

Financials

2024 2025
Net sales - -
Net income 10.44L 13.02L 11.16L 10L 17.93L 12Cr 18.17L 1.23Cr 48.09L 6.26Cr 48.9L 47.84L 21Cr -7L -8L -7L -6L -11.21L -7.79Cr -11.36L -77.11L -30.07L -3.91Cr -30.58L -29.91L -13Cr
Net Debt -67.53L -84.26L -72.18L -61.82L -1.16Cr -81Cr -1.18Cr -7.98Cr -3.11Cr -40Cr -3.16Cr -3.09Cr -133.95Cr -59.06L -73.68L -63.12L -54.06L -1.01Cr -70Cr -1.03Cr -6.98Cr -2.72Cr -35Cr -2.77Cr -2.71Cr -117.14Cr
Logo ARPIDA
EvoNext Holdings Ltd, previously Evolva Holding Ltd, is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.
Employees
-